XML 40 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Investment in Unconsolidated Entities, Florida Oncology Partners (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2017
USD ($)
Dec. 31, 2018
USD ($)
Term
Dec. 31, 2017
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2011
USD ($)
Nov. 30, 2017
USD ($)
Sep. 22, 2017
USD ($)
Florida Oncology Partners [Abstract]                
Outstanding lease obligation $ 200,000   $ 200,000          
Investments in unconsolidated entities 168,000 $ 164,000 168,000 $ 164,000        
Recorded distribution     60,000 274,000        
Due from related parties $ 1,141,000 169,000 1,141,000 169,000        
Condensed Income Statement Information [Abstract]                
Patient revenue     3,424,000 3,414,000        
USNC's equity in (loss) income     $ (743,000) (101,000)        
FOP [Member]                
Florida Oncology Partners [Abstract]                
Lease term     7 years          
Capital lease obligation           $ 5,800,000    
Percentage of guarantee obligations           25.00%    
Outstanding lease obligation   468,000   468,000        
Down payment of capital leases         $ 1,000,000      
Monthly payments for capital leases         $ 172,000      
Common stock awarded as a part of bankruptcy proceedings (in shares) | shares 10,820              
Investments in unconsolidated entities $ 0 132,000 $ 0 132,000        
Recorded distribution   950,000 0          
Due from related parties $ 223,000 169,000 $ 223,000 169,000        
Note bearing interest 6.00%   6.00%          
Outstanding amount $ 735,000 299,000 $ 735,000 299,000        
Accrued interest     30,000 2,000        
Allowance for note receivable 218,000   218,000          
Reduced carrying value of note 517,000   517,000          
Condensed Income Statement Information [Abstract]                
Patient revenue     2,953,000 678,000        
Rental income     1,252,000 2,517,000        
Net (loss) income     (1,918,000) 525,000        
USNC's equity in (loss) income     (465,000) 132,000        
Condensed Balance Sheet Information [Abstract]                
Current assets 401,000 664,000 401,000 664,000        
Noncurrent assets 16,570,000 18,961,000 16,570,000 18,961,000        
Total assets 16,971,000 19,625,000 16,971,000 19,625,000        
Current liabilities 3,974,000 3,228,000 3,974,000 3,228,000        
Noncurrent liabilities 15,360,000 16,842,000 15,360,000 16,842,000        
Equity (2,363,000) (445,000) (2,363,000) (445,000)        
Total liabilities and equity (deficit) 16,971,000 19,625,000 $ 16,971,000 19,625,000        
FOP [Member] | Maximum [Member]                
Florida Oncology Partners [Abstract]                
Amount of guarantee obligation           $ 1,433,000    
FOP [Member] | Office Space [Member]                
Florida Oncology Partners [Abstract]                
Lease term     10 years          
Loan amount             $ 4,106,000  
Outstanding Loan 3,660,000 4,100,000 $ 3,660,000 4,100,000        
Debt maturity period     7 years          
FOP [Member] | Radiation Therapy Center [Member]                
Florida Oncology Partners [Abstract]                
Lease term     10 years          
Capital lease obligation               $ 14,321,000
Loan amount 436,000   $ 436,000          
Monthly payments for capital leases 163,200 $ 160,000 $ 163,200 $ 160,000        
Maximum number of additional terms extended | Term     3          
Extension of agreement     5 years          
Percentage of increase of monthly payments each year     2.00%          
FOP [Member] | Letter of Credit [Member] | Office Space [Member]                
Florida Oncology Partners [Abstract]                
Letter of credit, amount $ 88,000   $ 88,000          
FOP [Member] | USNC [Member]                
Florida Oncology Partners [Abstract]                
Ownership percentage 24.00%   24.00%